OVERVIEW
During the forecast period (2020-2025), the North American market for interventional cardiology devices is projected to rise at a CAGR of 3.25%. Growing population growth, substantial rise in the number of PCI centers in the U.S., and long waiting time for treatment in Canada are described as the major driving factors in the demand for cardiac treatments.
TABLE OF CONTENT
1 North American Interventional Cardiology & Peripheral Vascular Devices Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 North American Interventional Cardiology & Peripheral Vascular Devices Market – Executive
Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 North American Interventional Cardiology & Peripheral Vascular Devices Market –
Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 North American Interventional Cardiology & Peripheral Vascular Devices Market – Industry
Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 North American Interventional Cardiology & Peripheral Vascular Devices Market – Market
Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 North American Interventional Cardiology & Peripheral Vascular Devices Market – Strategic
Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 North American Interventional Cardiology & Peripheral Vascular Devices Market – By Device
(Market Size – & million/billion)
8.1 Angioplasty Balloons
8.2 Angioplasty Stents
8.3 Catheters
8.4 Endovascular Aneurysm Repair (EVAR) Stent Grafts
8.5 Inferior Vena Cava (IVC) Filters
8.6 Plaque Modification Devices
8.7 Hemodynamic Flow Alteration Devices
8.8 Accessory Devices
8.8.1 Vascular Closure Devices
8.8.2 Introducer Sheaths
8.8.3 Guide Wires
8.8.4 Balloon Inflation Devices
9 North American Interventional Cardiology & Peripheral Vascular Devices Market – By
Geography (Market Size – & million/billion)
9.1 Introduction
9.2 US
9.3 Canada
9.4 Mexico
10 North American Interventional Cardiology & Peripheral Vascular Devices Market – Entropy
10.1 New product launches
10.2 M&A’s, collaborations, JVs and partnerships
11 North American Interventional Cardiology & Peripheral Vascular Devices Market Company
Profile (Key Players)
11.1 Market Share, Company Revenue, Products, M&A, Developments
11.2 Abbott Laboratories
11.3 Medtronic Inc.
11.4 Cook Medical, Inc.
11.5 B. Braun Melsungen AG
11.6 Boston Scientific Corporation
11.7 C. R. Bard, Inc.
11.8 W.L.Gore & Associates, Inc.
11.9 Biotronik SE & Co. Kg
11.10 Cordis Corporation
11.11 Covidien Plc
11.12 Company 11 & more
12 North American Interventional Cardiology & Peripheral Vascular Devices Market –
Appendix
12.1 Sources
12.2 Abbreviations